Everest Medicines Limited (HKG:1952)
Hong Kong · Delayed Price · Currency is HKD 39.54
-0.44 (-1.10%)
Apr 17, 2026, 2:15 PM HKT
Everest Medicines Market Cap
Everest Medicines has a market cap or net worth of 14.05 billion as of April 16, 2026. Its market cap has decreased by -30.89% in one year.
Market Cap
14.05B
Enterprise Value
12.04B
Revenue
1.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
39.54
Market Cap Chart
Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 14.05B, a decrease of -31.94%. That is a compound annual growth rate of -6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 14.05B | 7.52% |
| Dec 31, 2025 | 13.06B | -16.21% |
| Dec 31, 2024 | 15.59B | 132.87% |
| Dec 29, 2023 | 6.70B | 24.60% |
| Dec 30, 2022 | 5.37B | -47.96% |
| Dec 31, 2021 | 10.33B | -47.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 19.54B |
| Zai Lab | 19.38B |
| Ascletis Pharma | 18.94B |
| Nanjing Leads Biolabs | 18.56B |
| CStone Pharmaceuticals | 14.58B |
| HBM Holdings | 12.10B |
| CARsgen Therapeutics Holdings | 11.84B |
| Lepu Biopharma | 11.19B |